Functional probiotics and postbiotics featuring 20 ‘GRAS-designated raw materials’ draw growing interest
[by Kang, In Hyo] ILDONG Bioscience, a health functional food subsidiary of the Ildong Pharmaceutical Group, announced on May 27 its participation in the ‘2025 Vitafoods Europe.’ The company aims to showcase its portfolio of functional ingredients and actively pursue opportunities to strengthen its presence in the global market.
Vitafoods 바카라사이트 가입 is recognized as the largest healthcare food, beverage, and health functional food fair in 바카라사이트 가입. The 2025 edition of the event took place in Barcelona, Spain, from May 20 to 22, attracting more than 20,000 industry professionals representing 120 countries worldwide.
During the event, 바카라사이트 가입 Bioscience showcased its portfolio of functional ingredients while emphasizing its technological competitiveness in the probiotics and postbiotics sectors, particularly its proprietary quadruple coating processing technology. The company also engaged in a series of partnering meetings with global firms, aiming to establish strategic business alliances and identify potential partners to support its expansion into international markets.
“Our portfolio of approximately 20 or so ‘US GRAS (Generally Recognized As Safe) raw materials,’ along with ‘HALAL’ and ‘Kosher’ certified ingredients, as well as our functional materials, tailored to meet the specific needs of global markets, were highly regarded by visitors during the event,” an ILDONG Bioscience official stated.
“In addition to our sustained performance in the Asian and North American markets, we have been actively expanding our export channels to European countries, including Spain and Greece, since last year,” the official further commented. “Going forward, we intend to expand our network of trading partners and diversify our product offering through localized market strategies.”
ILDONG Bioscience, a health functional food company under Ildong Holdings, was established in 2016, leveraging Ildong Pharmaceutical’s proprietary technology and infrastructure in lactic acid bacteria. The company is engaged in the development of functional ingredients and finished products using probiotics and postbiotics, as well as in contract development and manufacturing (CDMO) services and the supply of raw materials.